Literature DB >> 15003661

Sero-epidemiology of Bordetella pertussis in England and Wales.

A Nardone1, R G Pebody, P A C Maple, N Andrews, N J Gay, E Miller.   

Abstract

The incidence of pertussis infection can be estimated in the population by defining a single high titre of anti pertussis toxin (PT) immunoglobulin G (IgG) antibody predictive of recent infection. Sera samples collected in 1986, 1996 or annually between 1987 and 1998 were tested for anti-PT IgG antibody. In 1996, the age-adjusted prevalence of pertussis infection was 1.2% and was higher in children than in adults. Amongst samples collected annually, older age and female sex, but none of the temporal variables, were associated with a serologically defined pertussis infection. There is an important incidence of infection in the population, which is greater amongst children than adults, but there is only limited evidence of a correlation with epidemic cycles.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15003661     DOI: 10.1016/j.vaccine.2003.08.039

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy.

Authors:  G Gabutti; M Bergamini; P Bonanni; M Guido; D Fenoglio; A Giammanco; L Sindoni; C Zotti; V Boddi; F Bamfi; R Severini; A Bechini; S Boccalini; P Crovari
Journal:  Epidemiol Infect       Date:  2008-01-16       Impact factor: 2.451

2.  Trends in hospital admission rates for whooping cough in England across five decades: database studies.

Authors:  Nick Haslam; Uy Hoang; Michael J Goldacre
Journal:  J R Soc Med       Date:  2014-02-13       Impact factor: 5.344

3.  Is Pertussis Infection Neglected in China? Evidence from a Seroepidemiology Survey in Zhejiang, an Eastern Province of China.

Authors:  Hanqing He; Pingping Yao; Yang Zhou; Xuan Deng; Jinren Pan
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

4.  Prevalence of high antibody titers of pertussis in Turkey: reflection of circulating microorganism and a threat to infants.

Authors:  Berrin Esen; Nilay Coplu; Demet Kurtoglu; Aysegul Gozalan; Levent Akin
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

5.  Strategic Approaches Towards Pertussis Control in Oman.

Authors:  Salah T Al Awaidy
Journal:  Oman Med J       Date:  2018-01

6.  Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia.

Authors:  Patricia Campbell; Peter McIntyre; Helen Quinn; Linda Hueston; Gwendolyn L Gilbert; Jodie McVernon
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

7.  Accelerating control of pertussis in England and Wales.

Authors:  Helen Campbell; Gayatri Amirthalingam; Nick Andrews; Norman K Fry; Robert C George; Timothy G Harrison; Elizabeth Miller
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883

Review 8.  Population (Antibody) Testing for COVID-19-Technical Challenges, Application and Relevance, an English Perspective.

Authors:  Peter A C Maple
Journal:  Vaccines (Basel)       Date:  2021-05-24

9.  Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program.

Authors:  Hans O Hallander; Mikael Andersson; Lennart Gustafsson; Margaretha Ljungman; Eva Netterlid
Journal:  APMIS       Date:  2009-12       Impact factor: 3.205

10.  The epidemiology of pertussis in Germany: past and present.

Authors:  Wiebke Hellenbrand; Dietmar Beier; Evelin Jensen; Martina Littmann; Christiane Meyer; Hanna Oppermann; Carl-Heinz Wirsing von König; Sabine Reiter
Journal:  BMC Infect Dis       Date:  2009-02-25       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.